Premium
Alpha‐tocopherol transport in the lung is affected by the apoE genotype—Studies in transgenic apoE3 and apoE4 mice
Author(s) -
Huebbe Patricia,
JofreMonseny Laia,
Rimbach Gerald
Publication year - 2009
Publication title -
iubmb life
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.132
H-Index - 113
eISSN - 1521-6551
pISSN - 1521-6543
DOI - 10.1002/iub.177
Subject(s) - apolipoprotein e , receptor , scavenger receptor , medicine , endocrinology , alpha (finance) , biology , apolipoprotein b , chemistry , biochemistry , cholesterol , lipoprotein , disease , construct validity , nursing , patient satisfaction
Apolipoprotein E (apoE) is a major constituent of lipoproteins mediating peripheral uptake of lipids including the lipid‐soluble vitamin alpha‐tocopherol (α‐toc). In a recent study, we observed significant lower α‐toc concentrations in the lung of apoE4 compared with apoE3 transgenic mice. In this study, we determined the mRNA levels of genes encoding for proteins centrally involved in the uptake, export, and degradation of vitamin E. Receptors of α‐toc uptake including scavenger receptor B1 (SR‐B1), LDL receptor (LDLrec), and LDLrec‐related protein 1 (LRP1) were lower in apoE4 when compared with apoE3 mice with statistical significance for SR‐B1 and LRP1. Lung mRNA levels of the ATP‐binding cassette A1 and the multidrug resistance transporter 1, surfactant proteins mediating the export of α‐toc, were lower in apoE4 than in apoE3 mice. In addition, the mRNA levels of cytochrome P450 3A, a microsomal enzyme family involved in the degradation of α‐toc, tended to be higher in the apoE4 when compared with the apoE3 genotype. Current data indicate that genes encoding for proteins involved in peripheral α‐toc transport and degradation are affected by the apoE genotype probably accounting for thelower α‐toc tissue concentration as observed in apoE4 mice. © 2009 IUBMB IUBMB Life, 61(4):453–456, 2009